Coherus BioSciences Inc at Robert W Baird Global Healthcare Conference Transcript
Why don't we go ahead and get started here? So good afternoon and thanks for joining us. I'm Mike Ulz, one of the biotech analysts here at Baird. It's my pleasure to introduce Denny Lanfear, President and CEO of Coherus BioSciences, which is a company focused on biosimilars, currently in the early stages of their launch of UDENYCA.
So the format for today is a fireside chat. So please feel free to ask questions if you have them. But first, I'll turn it over to Denny just to give us a brief background on the company before we jump into Q&A.
Thank you, Michael, and thank you all for joining us today. So we're very excited about 2019. I founded this company in 2010 with some former Amgen and Genentech colleagues, as you know. So this month, on September 20, we'll see the 9-year anniversary of the company's founding.
And I am personally highly gratified that we've
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |